Trial Profile
A prospective, observational study of Liraglutide in patients with Type 2 Diabetes with poor glycaemic control
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Sep 2016
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 16 Sep 2016 New trial record